182 related articles for article (PubMed ID: 32422321)
1. A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF.
Summer G; Kuhn AR; Munts C; Miranda-Silva D; Leite-Moreira AF; Lourenço AP; Heymans S; Falcão-Pires I; van Bilsen M
J Mol Cell Cardiol; 2020 Jul; 144():66-75. PubMed ID: 32422321
[TBL] [Abstract][Full Text] [Related]
2. Renal injury in relation to obesity and the additive effect of hypertension in female and male obese and lean ZSF1 rats.
Nguyen ITN; Cramer MJ; Joles JA; Verhaar MC
Am J Physiol Renal Physiol; 2023 Jul; 325(1):F73-F86. PubMed ID: 37227224
[TBL] [Abstract][Full Text] [Related]
3. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model.
Hamdani N; Franssen C; Lourenço A; Falcão-Pires I; Fontoura D; Leite S; Plettig L; López B; Ottenheijm CA; Becher PM; González A; Tschöpe C; Díez J; Linke WA; Leite-Moreira AF; Paulus WJ
Circ Heart Fail; 2013 Nov; 6(6):1239-49. PubMed ID: 24014826
[TBL] [Abstract][Full Text] [Related]
4. Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment.
Koser F; Hobbach AJ; Abdellatif M; Herbst V; Türk C; Reinecke H; Krüger M; Sedej S; Linke WA
Life Sci; 2022 Nov; 309():120998. PubMed ID: 36179815
[TBL] [Abstract][Full Text] [Related]
5. Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
Nguyen ITN; Brandt MM; van de Wouw J; van Drie RWA; Wesseling M; Cramer MJ; de Jager SCA; Merkus D; Duncker DJ; Cheng C; Joles JA; Verhaar MC
PLoS One; 2020; 15(5):e0232399. PubMed ID: 32374790
[TBL] [Abstract][Full Text] [Related]
6. Exercise Training Reveals Inflexibility of the Diaphragm in an Animal Model of Patients With Obesity-Driven Heart Failure With a Preserved Ejection Fraction.
Bowen TS; Brauer D; Rolim NPL; Bækkerud FH; Kricke A; Ormbostad Berre AM; Fischer T; Linke A; da Silva GJ; Wisloff U; Adams V
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066440
[TBL] [Abstract][Full Text] [Related]
7. Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction.
Miranda-Silva D; Wüst RCI; Conceição G; Gonçalves-Rodrigues P; Gonçalves N; Gonçalves A; Kuster DWD; Leite-Moreira AF; van der Velden J; de Sousa Beleza JM; Magalhães J; Stienen GJM; Falcão-Pires I
Acta Physiol (Oxf); 2020 Mar; 228(3):e13378. PubMed ID: 31520455
[TBL] [Abstract][Full Text] [Related]
8. Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction.
Leite S; Cerqueira RJ; Ibarrola J; Fontoura D; Fernández-Celis A; Zannad F; Falcão-Pires I; Paulus WJ; Leite-Moreira AF; Rossignol P; López-Andrés N; Lourenço AP
Circ Heart Fail; 2019 Jul; 12(7):e005596. PubMed ID: 31525070
[TBL] [Abstract][Full Text] [Related]
9. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
[TBL] [Abstract][Full Text] [Related]
10. Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility.
Adams V; Schauer A; Augstein A; Kirchhoff V; Draskowski R; Jannasch A; Goto K; Lyall G; Männel A; Barthel P; Mangner N; Winzer EB; Linke A; Labeit S
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1565-1581. PubMed ID: 35301823
[TBL] [Abstract][Full Text] [Related]
11. ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction.
Schauer A; Draskowski R; Jannasch A; Kirchhoff V; Goto K; Männel A; Barthel P; Augstein A; Winzer E; Tugtekin M; Labeit S; Linke A; Adams V
ESC Heart Fail; 2020 Oct; 7(5):2123-2134. PubMed ID: 32710530
[TBL] [Abstract][Full Text] [Related]
12. Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction.
Brandt MM; Nguyen ITN; Krebber MM; van de Wouw J; Mokry M; Cramer MJ; Duncker DJ; Verhaar MC; Joles JA; Cheng C
J Cell Mol Med; 2019 Oct; 23(10):6666-6678. PubMed ID: 31368189
[TBL] [Abstract][Full Text] [Related]
13. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
[TBL] [Abstract][Full Text] [Related]
14. Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction.
Neves JS; Leite AR; Conceição G; Gonçalves A; Borges-Canha M; Vale C; Von-Hafe M; Martins D; Miranda-Silva D; Leite S; Rocha-Oliveira E; Sousa-Mendes C; Chaves J; Lourenço IM; Grijota-Martínez C; Bárez-López S; Miranda IM; Almeida-Coelho J; Vasques-Nóvoa F; Carvalho D; Lourenço A; Falcão-Pires I; Leite-Moreira A
Thyroid; 2023 Aug; 33(8):983-996. PubMed ID: 37140469
[No Abstract] [Full Text] [Related]
15. Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain.
Schauer A; Adams V; Kämmerer S; Langner E; Augstein A; Barthel P; Männel A; Fabig G; Alves PKN; Günscht M; El-Armouche A; Müller-Reichert T; Linke A; Winzer EB
Circ Heart Fail; 2024 Jun; 17(6):e011107. PubMed ID: 38847102
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction.
Moreira-Costa L; Tavares-Silva M; Almeida-Coelho J; Gonçalves A; Trindade F; Vasques-Nóvoa F; Sousa-Mendes C; Leite S; Vitorino R; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
Eur J Pharmacol; 2024 Mar; 966():176336. PubMed ID: 38272343
[TBL] [Abstract][Full Text] [Related]
17. Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction.
Büttner P; Adams V; Werner S; Ossmann S; Besler C; Schwedhelm E; Thiele H
ESC Heart Fail; 2022 Dec; 9(6):4348-4351. PubMed ID: 36043453
[TBL] [Abstract][Full Text] [Related]
18. Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
Davila A; Tian Y; Czikora I; Li J; Su H; Huo Y; Patel V; Robinson V; Kapuku G; Weintraub N; Bagi Z
Circ Heart Fail; 2019 Aug; 12(8):e005762. PubMed ID: 31525084
[TBL] [Abstract][Full Text] [Related]
19. Histological and haemodynamic characterization of right ventricle in sedentary and trained rats with heart failure with preserved ejection fraction.
Oliveira MI; Leite S; Barros A; Lourenço AP; Mendes C; Schmidt C; Santos M; Leite-Moreira A; Moreira-Gonçalves D
Exp Physiol; 2021 Dec; 106(12):2457-2471. PubMed ID: 34676608
[TBL] [Abstract][Full Text] [Related]
20. Muscular changes in animal models of heart failure with preserved ejection fraction: what comes closest to the patient?
Goto K; Schauer A; Augstein A; Methawasin M; Granzier H; Halle M; Craenenbroeck EMV; Rolim N; Gielen S; Pieske B; Winzer EB; Linke A; Adams V
ESC Heart Fail; 2021 Feb; 8(1):139-150. PubMed ID: 33350094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
